Covalon Launches New “CLABSI Conscious” Campaign to Help Children Heal Without Infections

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV)  (OTCQX: CVALF), an advanced medical technologies company, is ramping up awareness about rising Central Line Associated Blood Stream Infection (“CLABSI”) rates across the U.S. with new digital resources designed to bring the standard infection ratio for CLABSI down, specifically in pediatric patients.

Covalon is taking a stand against the significant rise in the standard infection ratio for CLABSI through a new “CLABSI Conscious” campaign geared to minimize human error, maintain safety consistency, and empower frontline healthcare teams with the technology they need to reduce CLABSIs in pediatric patients.

“The CDC has reported a 47% increase in CLABSIs in US hospitals and a 65% increase in infections in intensive care units,” says Brian Pedlar, CEO of Covalon. “Sick children don’t deserve a CLABSI. While healthcare providers continue to deal with unprecedented challenges, there are effective and practical solutions at our fingertips to help all patients, especially children to heal with their best chance for recovery and comfort.”

Covalon’s new campaign focuses on the role that CLABSI-conscious technology can play in maintaining safety consistency across healthcare sites, teams, and procedures. The list of CLABSI prevention practices at most hospitals is long, including highly specialized sterilization protocols, hand hygiene mandates, training toolkits, and more, but the role that advanced technology plays is often overlooked. CLABSI-conscious technology can help support CLABSI protocols by preventing human error, streamlining workflows, and protecting patients using innovative dual-antimicrobial infection prevention formulas like silver combined with chlorhexidine.

As part of the CLABSI Conscious campaign, Covalon:

  • Launched a brand new blog that provides resources for healthcare professionals, patients and care providers on the role technology plays in compassionate care, improving patient outcomes, and infection prevention
  • Renewed its social media presence on LinkedIn, Twitter, Instagram, and Facebook with content that brings greater awareness to the social, emotional, and economic cost of infections, especially in vulnerable patients
  • Is hosting an expert-led webinar on November 9 in collaboration with Paula Lamagna, RN, Education Coordinator, Vascular Access Team, at Boston Children’s Hospital to address climbing CLABSI rates in pediatric patients. Webinar registration details are below.
Webinar Details

CLABSI Prevention: New Technology to Address Rising CLABIS Infection Rates in Pediatric Patients
Date: Thursday, November 10th at 1:00 pm EST, 10:00 am PST
Registration: Click here to register
Hashtag: #InfectionPrevention

“Healthcare leaders around the world are aware of the toll that frontline shortages, healthcare worker burnout, and the aftermath of the COVID-19 pandemic have taken on the provision of healthcare and patient outcomes,” says Brian Pedlar. “We are ramping up our resources, outreach, partnerships, and plans to help frontline teams save time, stop stressful setbacks from happening, and ultimately save lives.”

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy